Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies.
- DOI
- 10.7554/elife.109518
- Published
- 2026 Jun 23
- Container
- eLife
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7554/elife.109518,
title = {Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies.},
author = {Lin Y and Liou B and Fannin V and Adler S and Mayhew CN and Hammonds JE and Hu YC and Tchieu J and Zhang W and Zhao X and Beres RL and Setchell KDR and Kaynak A and Qi X and Feldman RA and Sun Y},
year = {2026},
journal = {eLife},
doi = {10.7554/elife.109518},
url = {https://doi.org/10.7554/elife.109518}
}RIS
TY - JOUR TI - Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. AU - Lin Y AU - Liou B AU - Fannin V AU - Adler S AU - Mayhew CN AU - Hammonds JE AU - Hu YC AU - Tchieu J AU - Zhang W AU - Zhao X AU - Beres RL AU - Setchell KDR AU - Kaynak A AU - Qi X AU - Feldman RA AU - Sun Y PY - 2026 JO - eLife DO - 10.7554/elife.109518 UR - https://doi.org/10.7554/elife.109518 ER -
APA
Y, L., B, L., V, F., S, A., CN, M., JE, H., YC, H., J, T., W, Z., X, Z., RL, B., KDR, S., A, K., X, Q., RA, F., & Y, S. (2026). Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies.. eLife. https://doi.org/10.7554/elife.109518
Source records
- pubmed · retrieved 2026-09-25T05:43:20.025Z